Meningitis
Inflammation of arachnoid/pia mater of brain, spinal cord, and CSF Septic (bacterial) or Aseptic (viral) Enter CNS indirectly or directly Resulting inflammatory response can ICP Exudate may spread to cranial/spinal nerves and cause neurologic deterioration
Clinical Manifestations
Headache Fever Nuchal rigidity Positive Kernigs sign Positive Brudinskis sign Photophobia Rash with N. meningitidis Disorientation Seizures
Prevention
Haemophilus influenzae meningitis is now rarely seen do to childhood vaccination College freshmen are targeted for vaccination against N. meningitidis Close contacts of patients with meningococcal meningitis (N. meningitidis) are treated prophylactically with rifampin (Rifadin), ciprofloxacin (Cipro) or ceftriaxone (Rocephin)
Management
Medical Early administration of antibiotics Dexamethasone Fluid volume expanders Dilantin for seizure control Nursing Neurological checks Monitor VS, SpO2, ABGs Maintain adequate tissue oxygenation Monitor arterial BP Rapid fluid replacement Prevent ICP Seizure management Prevent complications Maintain Infection Control
Encephalitis
Acute inflammation of brain tissue Most often viral
Herpes Simplex Virus Enteroviruses Arboviruses
Can also be caused by: bacteria, fungi, paracytes No exudate Can result in death
Diagnostics
The specific diagnostics will vary by cause Common diagnostics include
CSF analysis Neuroimaging (MRI) EEG
Assessment
Use GCS Clinical manifestations: fever, n/v, nuchal rigidity, headache, vertigo Seizure activity Cranial nerve involvement Indicators of ICP
What is the GCS? What does a GCS 15 tell you? A GCS 3? What signs are indicative of increased intracranial pressure?
Treatment
Multiple Sclerosis
Progressive, degenerative disease affecting:
Myelin sheath Conduction pathways of CNS
Leading cause of neurologic disability in 20 40 year olds 4 patterns Periods of remission and exacerbation
Pathophysiology
Sensitized T cells cross blood-brain barrier and remain in the CNS and promote entry of other agents that damage immune system Immune system attack leads to inflammation that destroys myelin and oligodendroglial cells Damaged myelin is removed by astrocytes and plaques develop on demyelinated axons
Pathophysiology
White fiber tracts are affected Recovery of myelin will occur with remission Repeated exacerbations will result in permanent damage caused by degeneration of the demyelinated axons
Clinical Manifestations
Fatigue Depression Weakness Numbness Ataxia Loss of balance Pain Absent abdominal reflexes Hyperactive DTRs Visual disturbances
diplopia
Secondary Complications
UTI Constipation Pressure ulcer Contractures Dependent pedal edema Pneumonia Reactive depression Decreased bone density Increased risk of osteoporosis
Gerontologic Considerations
Mrs. S is 60 years old and has had relapsing-remitting MS for 35 years. She had just been diagnosed with type 2 diabetes and her BP is now at a level that requires pharmacotherapy. With each exacerbation of her MS she seems to have increased functional deficits. Her functional abilities are also impaired by increasing weakness and a stooped posture. She has been hospitalized for an acute exacerbation and work-up that identified the diabetes mellitus. She has recovered to the point that she can be discharged to home but she is worried about being a burden.
Question As you are planning Mrs. Ss discharge, what factors must be considered?
Medication
Disease modifying therapy:
Interferon beta-1a Interferon beta-1b Glatiramer acetate Methylpredinisolone Mitoxantrone
Symptom management:
Baclofen Benzodiazepines Zanaflex Dantrolene Amantadine Pemoline Fluoxetine Alpha-adrenergic blockers Antispasmotics Vitamin C
Nursing Interventions
Promote physical mobiltiy Prevent injury Enhance bladder and bowel control Enhance communication & manage swallowing difficulties Improve sensory and cognitive function Improve home management Promote sexual function
Myasthenia Gravis
Chronic neuromuscular autoimmune disease Weakness of voluntary muscles Remissions and exacerbations Nerve impulse not transmitted to skeletal muscles Development of specific antibodies to one or more Ach receptor sites Degeneration of Ach receptors Thymus gland often abnormal
Clinical Manifestations
Ocular muscle involvement Bulbar weakness Generalized weakness Dysphonia
Describe the clinical presentation of these manifestations. What is a major associated risk?
Assessment/Diagnostics
AchE Inhibitor test: edrophonium (Tensilon) is injected IV Identification of Ach receptor antibodies in serum Repetitive Nerve Stimulation MRI
Medical Management
Medications:
Antichoinesterase Inhibitors (pyridostigmine) Immunosuppresive agents Corticosteroids Cytotoxic agents
Other:
Plasmppheresis Thymectomy
Interventions
Identify at least one strategy to:
Assist with activities Facilitate communication Provide respiratory support Provide nutritional support Provide eye protection Provide psychosocial support
Serious Complication
Respiratory Failure
Often precipitated by a respiratory infection Other triggers: medication change, surgery, pregnancy, medications that exacerbate MG
Discuss why respiratory failure would occur. What collaborative interventions would be necessary if respiratory failure occurs?
Cholinergic Crisis
Acute exacerbation of muscle weakness Overmedication with cholinergic drugs When is the best time for chest physiotherapy? What should the nurse offer after CPT?
Problem Identification Identify the key Collaborative Problem and Nursing Diagnosis associated with Myasthenia Crisis
Guillian-Barr Syndrome
Autoimmune attack on myelin of PNS Ascending weakness most typical Impaired saltatoy conduction Characterized by: dyskinesia, hyporeflexia, and paresthesia Antecedent event Most fully recover, but can result in death
Pathophysiology
Cell mediated and humoral immune attack Molecular mimicry Process results in influx of macrophages and other immune mediated agents that attack myelin Axon looses ability to conduct impulse
Clinical Manifestations
Classic presentation: Areflexia and ascending weakness Paresthesia Pain Blindness Respiratory compromise Autonomic dysfunction
Medical Management
Baseline respiratory assessment and close monitoring
Continuous ECG monitoring
Anticipate need for intubation and mechanical ventilation Plasmapheresis and IV Immunoglobulin G (IVIG) Short acting alpha adrenergic beta blockers
Nursing Interventions
Identify interventions that will: Maintain respiratory and cardiovascular function Enhance physical mobility Provide adequate nutrition Improve communication Decrease fear and anxiety Monitor and manage potential complications